Observational studies suggest that bariatric-metabolic surgery might greatly improve non-alcoholic steatohepatitis (NASH). However, the efficacy of surgery on NASH has not yet been compared with the effects of lifestyle interventions and medical therapy in a randomised trial.

Verrastro, O., Panunzi, S., Castagneto-Gissey, L., De Gaetano, A., Lembo, E., Capristo, E., Guidone, C., Angelini, G., Pennestrì, F., Sessa, L., Vecchio, F. M., Riccardi, L., Zocco, M. A., Boskoski, I., R Casella-Mariolo, J., Marini, P., Pompili, M., Casella, G., Fiori, E., Rubino, F., R Bornstein, S., Raffaelli, M., Mingrone, G., Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial, <<THE LANCET>>, 2023; 401 (10390): 1786-1797. [doi:10.1016/S0140-6736(23)00634-7] [https://hdl.handle.net/10807/322076]

Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial

Verrastro, Ornella;Panunzi, Simona;Lembo, Erminia;Capristo, Esmeralda;Guidone, Caterina;Angelini, Giulia;Sessa, Luca;Vecchio, Fabio Maria;Riccardi, Laura;Zocco, Maria Assunta;Boskoski, Ivo;Pompili, Maurizio;Casella, Giovanni;Raffaelli, Marco;Mingrone, Geltrude
2023

Abstract

Observational studies suggest that bariatric-metabolic surgery might greatly improve non-alcoholic steatohepatitis (NASH). However, the efficacy of surgery on NASH has not yet been compared with the effects of lifestyle interventions and medical therapy in a randomised trial.
2023
Inglese
Verrastro, O., Panunzi, S., Castagneto-Gissey, L., De Gaetano, A., Lembo, E., Capristo, E., Guidone, C., Angelini, G., Pennestrì, F., Sessa, L., Vecchio, F. M., Riccardi, L., Zocco, M. A., Boskoski, I., R Casella-Mariolo, J., Marini, P., Pompili, M., Casella, G., Fiori, E., Rubino, F., R Bornstein, S., Raffaelli, M., Mingrone, G., Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial, <<THE LANCET>>, 2023; 401 (10390): 1786-1797. [doi:10.1016/S0140-6736(23)00634-7] [https://hdl.handle.net/10807/322076]
File in questo prodotto:
File Dimensione Formato  
Bariatric-metabolic survery versus lifestyle intervention.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 271.72 kB
Formato Adobe PDF
271.72 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/322076
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 221
  • ???jsp.display-item.citation.isi??? 216
social impact